CAJ | 학술논문

目的探讨动态血糖监测系统在孕中晚期妊娠糖尿病(GDM)孕妇中的应用价值.方法对2006年1月-2007年4月门诊进行孕期健康检查的妊娠中晚期(24～35周)孕妇进行GDM的筛查,首先进行50g葡萄糖筛查试验,如1h血糖≥7.8mmol/L,则进一步于3d后行100g口服葡萄糖耐量试验.根据美国糖尿病协会诊断标准,将筛查出的47例GDM孕妇随机分成2组,实验组25例行72h动态血糖监测(CGMS),对照组22例行72h指尖末梢血糖测试,7次/d(包括三餐前、三餐后及睡前).结果所有GDM孕妇在监测过程中均无低血糖自觉症状及低血糖事件记录;CGMS数据显示实验组高血糖比为(17.5±3.1)%,低血糖比为(2.4±0.9)%,均明显高于对照组的(14.3±2.2)%及0.结论建议采用血糖仪行血糖自我监测的GDM孕妇,在进行指尖末梢血糖测试的同时定期进行CGMS血糖监测,系统评价真实血糖控制情况,确保母婴安全.
목적 탐토동태혈당감측계통재잉중만기임신당뇨병(GDM)잉부중적응용개치.방법 대2006년1월-2007년4월문진진행잉기건강검사적임신중만기(24～35주)잉부진행GDM적사사,수선진행50g포도당사사시험,여1h혈당≥7.8mmol/L,칙진일보우3d후행100g구복포도당내량시험.근거미국당뇨병협회진단표준,장사사출적47례GDM잉부수궤분성2조,실험조25례행72h동태혈당감측(CGMS),대조조22례행72h지첨말소혈당측시,7차/d(포괄삼찬전、삼찬후급수전).결과 소유GDM잉부재감측과정중균무저혈당자각증상급저혈당사건기록;CGMS수거현시실험조고혈당비위(17.5±3.1)%,저혈당비위(2.4±0.9)%,균명현고우대조조적(14.3±2.2)%급0.결론 건의채용혈당의행혈당자아감측적GDM잉부,재진행지첨말소혈당측시적동시정기진행CGMS혈당감측,계통평개진실혈당공제정황,학보모영안전.
Objective We aimed to describe the application value of continuous glucose monitoring system in patients with advanced gestational diabetes mellitus (GDM). Methods Pregant women in the medium and late pregant phases (24～35 weeks) underwent GDM screen test from January 2006 to April 2007. They first received 50 g glucose challenge test and 100g OGTT was performed 3 days later when the blood glucose was higher than or equal to 7.8mmol/L. According to the diagnostic criteria from American Diabetes Mellitus (ADA) 47 women were diagnosed to possess GDM and they were further divided into the test group (25 cases) and the control group (22 cases). The test group received 72 hours continuous glucose monitoring (CGMS). The control group adopted peripheral blood glucose monitoring using blood from the fingertip, 7 times per day. Results There were no records of consciousness hypoglycemic symptoms and hypoglycemia during monitoring. The CGMS data suggested that the record of the percent of high blood glucose was (17.5±3.1)%, percent of low blood glucose was (2.4±0.9)%, which were higher than those of the control group, which were (14.3±2.2)% and 0. Conclusions We recommend pregant women with GDM to undergo CGMS while using peripheral blood glucose monitoring with blood from the fingertip. It could systemicly evaluate the real control condition of blood glucose and ensure the safety of both mothers and babies.